在帕金森病中循环功能障碍的代谢基础
Priya Rathor1,2, Ratnasekhar Ch1,2,3
1Metabolomics Lab, CSIR-Central Institute of Medicinal & Aromatic Plants, Lucknow 226015, India.
Biology
|October 27, 2023
概括
循环功能障碍破坏细胞代谢,增加帕金森病 (PD) 的风险. 了解这种联系可能会导致神经退行症的新疗法,并改善PD患者的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 代谢研究的研究.
- 时间生物学 时间生物学
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元的逐渐丧失.
- 线粒体功能障碍和能量代谢的改变与PD病变发生有关.
- 新出现的证据强调了昼夜功能障碍在PD中的重要作用.
研究的目的:
- 审查昼夜功能障碍,细胞代谢和帕金森病之间的关系.
- 总结关于这种相互作用的动物模型和人类研究的证据.
- 探索潜在的治疗策略,以恢复PD的昼夜节律为目标.
主要方法:
- 文献综述综合动物模型的发现.
- 对研究昼夜节律和PD的人类研究的分析.
- 检查PD中昼夜功能障碍的代谢基础.
主要成果:
- 循环功能障碍和睡眠障碍在PD患者中很普遍.
- 昼夜节律的扰乱与患PD的风险增加有关.
- 有证据表明,昼夜节律扰乱,代谢干扰和多巴胺基神经元存活之间存在联系.
结论:
- 了解PD中昼夜功能障碍的代谢基础对于开发新的治疗方法至关重要.
- 恢复昼夜节律可能有助于维护多巴胺功能并减缓PD进展.
- 对昼夜节律与PD相互作用的进一步研究对于有针对性的干预措施至关重要.
相关概念视频
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
69
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
69
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Factors Affecting Drug Biotransformation: Biological
156
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
156


